# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-015017
Filing Date
2023-05-18
Accepted
2023-05-18 07:00:40
Documents
28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | nby20230515_def14a.htm iXBRL | DEF 14A | 726686
6 |  | b01.jpg | GRAPHIC | 44433
7 |  | gph01.jpg | GRAPHIC | 195544
8 |  | gph02.jpg | GRAPHIC | 164300
9 |  | i01.jpg | GRAPHIC | 766
10 |  | i02.jpg | GRAPHIC | 770
11 |  | i04.jpg | GRAPHIC | 794
12 |  | img02.jpg | GRAPHIC | 35628
13 |  | img.jpg | GRAPHIC | 776
14 |  | nby20230503_pre14aimg001.jpg | GRAPHIC | 5110
15 |  | nby20230503_pre14aimg002.jpg | GRAPHIC | 2297
16 |  | nby20230503_pre14aimg003.jpg | GRAPHIC | 3495
17 |  | nby20230503_pre14aimg004.jpg | GRAPHIC | 3120
18 |  | nby20230503_pre14aimg005.jpg | GRAPHIC | 5110
19 |  | nby20230503_pre14aimg008.jpg | GRAPHIC | 2243
| Complete submission text file | 0001437749-23-015017.txt |  | 2541802

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20221231.xsd | EX-101.SCH | 6973
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20221231_def.xml | EX-101.DEF | 8771
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20221231_lab.xml | EX-101.LAB | 17218
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20221231_pre.xml | EX-101.PRE | 8794
22 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20230515_def14a_htm.xml | XML | 115289

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 23933673
SIC: 2834 Pharmaceutical Preparations